Advanced Search
Contact | Corporate | Help

Daily news email for July 27, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
2. Laupheimer Zelltage Attracts Top Scientists to Discuss Recent Advances in Biomanufacturing

Antisense Pharma Receives FDA Orphan Drug Designation for Trabedersen to Treat Malignant Melanoma

Sartorius Stedim Biotech Recognized as Innovations Honoree for FlexMoSys

New Campaign for Rentschler's 'Facility of the Year'

Berthold Awards Marlene DeLuca Prices

 BioSpace
Scientists Reveal New Clues to Alzheimer's Risk Gene, University of Southampton Study

Mutation Rates in Cancer Cells Strongly Linked to How Chromatin is Organized, Reveals

Where You Look Predicts What You're Going to Say, University of Edinburgh Study

BioCon Limited Close to Oral Insulin Deal With Bristol-Myers Squibb Company

Position of Merck Serono Concerning the Recommendation Made by of Geneva

BioSpace - Breaking News
Novogen Limited Announces Merger Agreement With and Distribution of MEI Pharma (MEIP) (Formerly known as Marshall Edwards, Inc.) Shares

ViroPharma Incorporated's Cinryze® (C1 esterase inhibitor [human]) Open Label Prophylaxis Study Showed Up to 2.6 Years of Effectiveness in Majority of Subjects With Hereditary Angioedema

Velos, Inc. Unveils eResearch Version 9

Roche and AREVA Med LLC Join Forces in the Fight Against Cancer and Create a Novel Radio-Immunotherapy

NSF International Acquires a Leading Clinical, Regulatory and Scientific Consulting Firm Specializing in the FDA-Regulated Medical Devices, Pharmaceuticals and Biologics Industries

Biotech News - Business Wire
Supersonic Imagine kondigt de productie aan van haar 500e Aixplorer®-ultrasoundsysteem in de wereld

Supersonic Imagine meldet die Herstellung seines weltweit 500. Aixplorer®-Ultraschallsystems

Research and Markets: US Biotechnology Industry: Sector Report - Market Size and Key Trends

Research and Markets: Japanese Biotechnology Industry: Sector Report - Market Size and Key Trends

Supersonic Imagine Announces the Production of its 500th Aixplorer® Ultrasound System in the World

 Biotech News - PR Newswire
Absorption Systems announces novel test platform for interactions with the BCRP transporter

Novogen Announces Merger Agreement With Kai Medical And Distribution Of Mei Pharma Shares

Bacterin International Holdings, Inc. Schedules Second Quarter 2012 Financial Earnings Conference Call

Eklira®/Bretaris® Genuair® (bromuro di aclidinio) approvato in Europa per la terapia di mantenimento della broncopneumopatia cronica ostruttiva (BCPO)

La Comisión Europea aprueba Fycompa® (perampanel) de Eisai la primera aprobación en el mundo para una nueva clase de tratamiento contra la epilepsia
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Building a Better Cancer Drug

Alzheimer's Drug Fails Late-Stage Trial

The August 2012 Issue of The Burrill Report

Tools Companies Expand in Diagnostics

FDA approves Onyx Multiple Myeloma Drug

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Research and Markets: Bronchiectasis Global Clinical Trials Review, H1, 2012

Research and Markets: Global Genetic Testing Market Forecast to 2015

Research and Markets: Thromboembolism Global Clinical Trials Review, H1, 2012

Pri-Med's Integrated Approaches to Cardiometabolic Care Conference Demonstrates Strong Demand for Case-Based Learning Between Specialists and Primary Care Teams

Study Highlights Need for More Access to Most Effective Birth Control Methods

 Clinical Trials - PR Newswire
Expanded Analysis of HPTN 052 Study Results Show Cost-Effectiveness of Early Treatment of HIV

Once-Daily Dolutegravir is Non-Inferior to Twice-Daily Raltegravir in Treatment-Naive Adults with HIV-1

Expanded Analysis of HPTN 052 Study Results Reveal Additional Benefits of Early HIV Treatment

Parkinson's Disease Foundation Invites Community to Join Research Advocates In Speeding New Treatments

Great Lakes Pharmaceuticals, Inc. announces initiation of clinical trial of the catheter lock solution, B-Lock

 CNN Top Stories
Bullied kids get free plastic surgery

Custody of Jackson kids to be shared

Cops: Man wanted to kill, eat boy

Outgunned Syrian rebels get stronger

'Horrific massacre' feared in Aleppo
Contract Pharma
Ricerca Launches Preclinical Assays

Onyx Expands Capabilities

Bio-Rad, Myriad RBM To Commercialize Biomarker Kits

Dalton Helps Duke-NUS Achieve Clinical Milestone

Financial Report: Alexion

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Riesgo de convulsiones en pacientes con esclerosis múltiple que toman Ampyra (dalfampridine)

FDA Drug Safety Communication: Seizure risk for multiple sclerosis patients who take Ampyra (dalfampridine)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva información sobre la prolongación del intervalo QT con ondansetrón (Zofran)

FDA Drug Safety Communication: New information regarding QT prolongation with ondansetron (Zofran)

 FDA News - Business Wire
Samenvatting: ARIAD start fase 3 studie van Ponatinib bij patiënten met chronische myeloïde leukemie

USFDA Lifts Import Alert from Dr. Reddy's Chemical Manufacturing Facility at Cuernavaca, Mexico

Neurotez., Inc. Announces Grant of U.S. Patent 8,227,408  around Its Leptin Therapy for Alzheimer's Disease

Bracco Diagnostics Receives U.S. FDA Approval for Expanded Labeling of MultiHance® (gadobenate dimeglumine) Injection in Magnetic Resonance Angiography

NSF International Acquires Becker & Associates Consulting, Inc., a Leading Clinical, Regulatory and Scientific Consulting Firm Specializing in the FDA-Regulated Medical Devices, Pharmaceuticals and Biologics Industries
FDA Press Releases
FDA approves Tudorza Pressair to treat chronic obstructive pulmonary disease

FDA: More than 150 antiretroviral drugs available through PEPFAR for worldwide HIV/AIDS relief

FDA warns consumers not to eat shellfish from Oyster Bay Harbor, Nassau County, NY

FDA approves Afinitor for advanced breast cancer

FDA approves Kyprolis for some patients with multiple myeloma

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking - Information for Consumers

Package Insert - Twinrix

Direct Recall Classification Program

Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

 FierceBiotech
UPDATED: FDA OKs Amarin's blockbuster heart drug contender AMR101

Analysts: Ailing Elan casts buyout bait for Biogen Idec

ThromboGenics wins FDA panel nod for eye drug

EU nod expands market for Vertex's CF drug Kalydeco

Buzz: HGS passed up $7B Amgen bid back in the day
FierceBiotech IT
Complete Genomics, Ingenuity combine forces to understand genomes

China, low-cost markets lead future eClinical tech growth

New York Genome Center finds new digs

10 Reasons Why Biotech Needs Big Data

WorldOne takes over Sermo social network for docs

 FierceBiotech Research
New eye injection drug helped blind mice see (for a while)

Yale team develops drug-targeting method for once-untouchable proteins

Cancer gene found to propel metastasis of breast cancer stem cells

Novel class of Alzheimer's drugs looks promising in animals

A handful of genetic mutations drive acute leukemia transformation

 FiercePharma
EU OKs Vertex cystic fibrosis drug Kalydeco

Analysts see sale of Elan to Biogen Idec as likely

With FDA panel nod, ThromboGenics closer to first potential drug

Regeneron expanding as its sees higher sales with Eylea

Amarin prepared for aggressive launch of billion-dollar fish oil
FiercePharma Manufacturing
EU counterfeit drug seizures surge; most fakes from China

Production jobs to be hot for next 5 years

California county orders drugmakers to pay for drug disposal

Sun Pharma standardizing manufacturing globally

FDA to Congress: Agency can't dodge plant problems to avoid shortages

 FierceVaccines
FDA wags finger at Sanofi for no-nos at vaccine plants

GE, iBio unite on plant-based production of vaccines and biologics

Sanofi vaccine combats most viral causes of dengue

Vaxil BioTherapeutics debuts on Tel Aviv Stock Exchange

UPDATED: Researchers hope to turn white blood cells into a vaccine

 Health News - BizJournals.com
SCCC board set to renew contract for president Bullock

Earnings: LifePoint flat in Q2

Think robotic surgery is going away FDA approves new one

CACI awarded $45M contract with National Institutes of Health

Phila.-area ER move designed to reduce wait times
Health News - CNBC
Fiber-added foods may not stem your hunger

Ex-smokers have higher risks for bowel diseases

Government on track with federal health exchanges: official

Death certificates may not tell the whole story

U.S. appeals court upholds Philip Morris sanctions

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Vertex Cystic Fibrosis Drug Wins European Approval

Vertex CF Drug Wins European Approval

BMS Awards Grants Focused on Combatting HBV and HCV in China and India

Life Science Tool Providers Boast Impressive Sales

Nuvo Gets $5.4M for Immune-Modulating Drug
Marketwire - Pharma and Biotech
Sarepta Therapeutics Regains NASDAQ Compliance

MMRGlobal to File Anti-CD20 Antibody and B-Cell Vaccine Patents Targeting Cancers

Insulet Corporation to Report Second Quarter 2012 Financial Results on August 8, 2012

Immunovative, Inc. Announces Formation of a Business Advisory Board and the Appointment of Bruno Vanderschelden as Chairman

Ingen Finalizes National Sales Program for Medical Product

 MassBio News
State, Local and Industry Officials Join KeraFAST to Open New Headquarters in Boston, MA

MLSC 2012 Capital Program Announcement

2012 Tax Incentive Program Announcement

Q&A With Jonathan Thomas

Policy Update

 Medical Pharma - PR Newswire
CVS Caremark Corporation To Hold Second Quarter 2012 Conference Call

Top Ten Obesity Risks Infographic

Regulatory Education and Action for Patients (REAP) Policy Forum Addresses Leading Challenges in 2013 Poised to Impact Patients' Access to Health Care

Heraeus Survey Invites Customers to Share "What they Really Think"

SOAPware Announces Meaningful Use (MU) Roadshow
National Center for Biotechnology Information
GenBank Submission Tools Announcements

GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

 Nature Biotechnology
Incorporating biomarkers into clinical trial designs: points to consider

TAL effector RVD specificities and efficiencies

Gene therapy matures in the clinic

From academic solos to industrial symphonies

Reading cancer's blueprint

 New York Times- Biotechnology
Novel Blood Treatment Lures Athletes in Pain to Germany

Athletes With Chronic Pain Turn to Novel Blood Treatment

Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment
New York Times- Pharmaceuticals
For Big Drug Companies, a Headache Looms

Deals to Keep Generic Drugs Off Market Get a Court Rebuff

‘Pay-for-Delay’ Drug Case Moves Forward

Eli Lilly and Bristol-Myers Profits Fall on Generic Drug Competition

Doctors Petition for Limits on Painkillers

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
Samenvatting: EU keurt Vertex KALYDECO goed; 1e medicijn die onderliggende oorzaak van cystic fibrosis aanpakt

Complera®, el régimen de pastilla única una vez al día de Gilead, mantiene la supresión del VIH en pacientes que dejan de someterse al régimen basado en inhibidores de proteasa

Covidien gibt Ergebnisse des dritten Quartals bekannt

Top Pharmaceuticals Companies & Activities Reviewed in New GlobalData Study Now Available at MarketPublishers.com

Resumen: Vertex obtiene aprobación europea para KALYDECO (ivacaftor), el primer medicamento en tratar la causa subyacente de la fibrosis quística en personas con una mutación genética específica (G551D)

 Pharma News - PharmiWeb
Aflac Incorporated to Webcast, Live, at RetailInvestorConferences.com on August 2nd

Metabolix Reports Second Quarter 2012 Financial Results and Provides Business Update

Kam Aims Uses Cloud Technology to Bring Affordable Solution to Freestanding Ambulatory Surgery Centers

Net Medical Xpress Announces Major Expansion and Upgrade for Growing Hospital Market

Texas Vascular Associates Sued in Dallas for Alleged Medicare, Insurance Fraud

 Pharma News - PR Newswire
LycoRed Group acquiert Vitan, renforçant sa position de leader sur le marché mondial des caroténoïdes naturels

GP Strategies to Report Second Quarter 2012 Results on August 2, 2012

ViroPharma's Cinryze® (C1 esterase inhibitor [human]) Open Label Prophylaxis Study Showed Up To 2.6 Years Of Effectiveness In Majority Of Subjects With Hereditary Angioedema

MedVantx Pharmacy Services Receives Coveted VIPPS Accreditation (Verified Internet Pharmacy Practice Sites)

Mylan Launches Generic Version of Sporanox® Capsules
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
Superior Insulation and No Drip Spouts Make the New Scienceware®...

Video on 'Symptoms of Diabetes' Released by Symptoms and...

Sunbelt Staffing to Attend American Speech-Language-Hearing...

Mold Remediation Products Cut Prices; Molderizer, MoldStat Giving Up...

KFI Radio Host Tim Conway, Jr. to MC Lung Cancer Foundation of...
PRWeb - Pharmaceuticals
Top Legal Steroids Proudly Announces Release of the Anabolic Pro...

Medmeme Reports On Pharma Activities To Meet Metabolic Disorders...

Good News! The Biggest Russian Language Publication in USA, The Health...

Medical Marketing Service Inc. Shares Successful Email Marketing...

MIDEGO Inc. Presents: Global Health Leaders with Dr. Elvira...

 Scientific American
Early HIV Treatment Might Save Livelihoods as Well as Lives

Tropical Parks Fail to Protect Animals and Plants [Slide Show]

Social Scientists Might Gain Access to Facebook's Data on User Behavior

Drought Devastates U.S. Maize and Soya Crops

Our Brains See Men as Whole and Women as Parts

 Sports - ESPN Basketball
Iona recruit Haynes shot and killed in Chicago

Ex-Hoosier Reed, figure in Knight's firing, dies

Villanova, Purdue in 2K Sports Classic semis

Semifinals set for Legends Classic in Brooklyn

Tar Heels to tip off in Maui vs. Mississippi State
Sports News - ESPN
Penn State LB Mauti: Scandal not players' fault

Victim 2 lawyers threaten lawsuit, cite evidence

2012 Big Ten Media Days

Source: USC DE Kennard (pec) could miss year

Longtime Idaho broadcaster Curtis dies at 87

 Xconomy Life Sciences
Siluria Attracts Paul Allen, Gets $30M to Turn Natural Gas Into Chemicals, Fuels

Lantos Raises $3.8M to Push 3D Ear Scanner Closer to Market

Allan Jones, the Force Behind Paul Allen's Vision for Brain Science

Bluebird Bio Snags $60M From Existing VCs and Newcomers Like Shire

Pet Dogs Help Biotech Startups Find New Weapons to Fight Cancer

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012